Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains 2.11% in September (7.29% YTD) as affordable Care Act and demographics boost healthcare sector

Monday, October 14, 2013
Opalesque Industry Update - Hedge funds gained 2.11% in September 2013, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 7.30% year to date.

“The Fed’s decision to delay tapering surprised investors and drove equity prices higher through mid-month,” says Sol Waksman, founder and president of BarclayHedge.

“Fears over the possible failure of US budget and debt ceiling negotiations gained momentum and equity markets sold off in the second half of September, but equities remained profitable on the month as measured by a gain of 5.0 percent for the MSCI World Index.”

All but one of Barclay’s 18 hedge fund indices had gains in September. The Barclay Healthcare & Biotechnology Index jumped 4.26%, Equity Long Bias gained 3.65%, the Technology Index was up 3.35%, Emerging Markets added 2.92%, Pacific Rim Equities gained 2.62%, and European Equities were up 2.03%.

The only losing hedge fund strategy in September was the Equity Short Bias Index, which lost 3.55%. Equity Short Bias is down 19.84% year to date, and the index is on track to match the 24.12% loss suffered in 2012.

After three quarters in 2013, the Healthcare & Biotechnology Index has gained 20.93%. Pacific Rim Equities are up 17.20%, the Equity Long Bias Index has gained 15.24%, Distressed Securities have returned 11.37%, and Technology is up 9.38%.

“Healthcare and Biotechnology is BarclayHedge’s top-performing hedge fund index year to date, and is on track for its best yearly performance since enjoying a 27.91% gain in 2009,” says Waksman.

“The passage of the Affordable Care Act in the US, coupled with the expectation of greater demand for healthcare services due to increases in both population and life expectancy have had a very positive impact on the sector.”

The Barclay Fund of Funds Index gained 1.33% in September, and has returned 4.95% year to date.

Click here to view five years of Barclay Hedge Fund Index data or download 16 years of monthly data.

Press release

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for